Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-022096
Filing Date
2014-06-02
Accepted
2014-06-02 16:56:44
Documents
1
Period of Report
2014-05-29

Document Format Files

Seq Description Document Type Size
1 GUETH MAY 29 rrd410729.html 4  
1 GUETH MAY 29 rrd410729.xml 4 3964
  Complete submission text file 0001181431-14-022096.txt   5501
Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020
ANTARES PHARMA, INC. (Issuer) CIK: 0001016169 (see all company filings)

EIN.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address
Business Address
GUETH ANTON (Reporting) CIK: 0001274940 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32302 | Film No.: 14884803